Spot® – The first and only non-India-ink-based product for marking the GI tract.
What it can do
Spot® is the only non-India-ink-based product for endoscopically marking lesions in the GI tract. Each syringe contains 5cc of a sterile, non-pyrogenic suspension containing highly purified carbon particles which create a permanent mark on the mucosal and serosal surfaces of the colon.
Why it’s better for your patients
Spot is the only non-India-ink-based product for marking lesions in the GI tract approved by the U.S. Food and Drug Administration.
India ink preparations contain shellac, phenol, and ammonia that, even in dilute solutions, should be avoided. Spot’s biocompatible, non-toxic formulation contains no India ink.
Spot is a single-use product, so sterility is easily maintained. Each syringe is steam-sterilized prior to packaging and shipping.
Why it’s better for you
Each syringe is prefilled.
Preparation is simplified thanks to Spot’s ready-to-use product design. Each syringe comes with 5cc of the marking fluid. Just shake it vigorously prior to use.
It’s easy to work with.
Spot is easier to use than India-ink-based markers, and it has a shelf life of two years.
India ink substitutes, such as methylene blue, don’t last very long. Metal clips have been used as markers, but they often fall off. Spot is permanent when injected into the submucosal tissue. On follow-up endoscopy or surgery, Spot’s marking will be there.
What clinical studies show
A clinical study concluded that Spot “eliminates the cumbersome preinjection processing required with India ink. Spot can be used to permanently mark the colon and appears to have the same, if not better, safety profile as India ink.”
Spot is a trademark of GI Supply
For orders or enquiries contact Fleetwood Healthcare: Tel: +353 1 2014620 Email: email@example.com